Go Pro

Lexaria Bioscience (LEXX) News Today

Lexaria Bioscience logo
$10.35 -1.33 (-11.39%)
As of 08/28/2026 04:00 PM Eastern

Lexaria Bioscience Latest News

Lexaria Bioscience Corp.
LEXX: First Quarter Results
Lexaria Bioscience Corp.: Lexaria Awarded Six Additional Patents
LEXX: Biodistribution Study Results
LEXX: Third Quarter Results
LEXX - Lexaria Bioscience Corp Dividends - Morningstar
Lexaria provides GLP-1 update following industry developments
Lexaria Bioscience begins dosing for GLP-1 study #5
Lexaria Bioscience granted two new DehydraTECH patents
Lexaria begins biodistribution study for DehydraTECH GLP-1
Lexaria Bioscience provides update on ongoing human study GLP-1-H24-4
Lexaria Bioscience forms Scientific Advisory Board
Lexaria Bioscience completes dosing for GLP-1 human pilot study #3
Lexaria Bioscience provides GLP-1 industry update

Lexaria Bioscience Media Mentions By Week

Lexaria Bioscience Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LEXX
News Sentiment

0.96

0.98

Average
Healthcare
News Sentiment

Lexaria Bioscience News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LEXX Articles
This Week

2

1

LEXX Articles
Average Week

Lexaria Bioscience Trends on MarketBeat

This week vs. last week
Searches
1
Page Views
1,291
+29%
Get Lexaria Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for LEXX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Lexaria Bioscience dated 8/13/2026.
From Our Partners